aluates Reports

$ 0.0

Automative

Global Digital Companion Diagnostics Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-14Q1973

Global Digital Companion Diagnostics Market Insights and Forecast to 2028

BUY CHAPTERS

Global Digital Companion Diagnostics Market Research Report 2025

Code: QYRE-Auto-14Q1973

Report

September 2025

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Myriad Genetic Laboratories Inc.

Roche

Abbott

ICON

Illumina Inc

Thermo Fisher

Qiagen Manchester, Ltd.

Dako North America

Digital Companion Diagnostics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Digital Companion Diagnostics Market

The global market for Digital Companion Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

A companion diagnostic is a medical device, often an in vitro device, which provides information that is essential for the safe and effective use of a corresponding drug or biological product. The test helps a health care professional determine whether a particular therapeutic product’s benefits to patients will outweigh any potential serious side effects or risks.Digital Companion Diagnostics (CD) refer to a type of in vitro diagnostic tests or assays that are intended to help physicians in making effective treatment decisions based on the patient’s response to a specific drug targeted toward a specific biomarker, expressed in a particular disease or indication. The patient’s response to an ongoing therapy is mapped with the help of companion diagnostics in terms of changes in gene amplification, nullifying the effect of mutations, changes in protein overexpression and receptor-substrate interaction, and so on.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Digital Companion Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital Companion Diagnostics.

The Digital Companion Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Digital Companion Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Digital Companion Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Digital Companion Diagnostics Market Report

Report Metric	Details
Report Name	Digital Companion Diagnostics Market
CAGR	5%
Segment by Type	Polymerase Chain Reaction (PCR) Immunohistochemistry (IHC) In Situ Hybridization (ISH) Next Generation Sequencing (NGS)
Segment by Application	Breast Cancer Melanoma Lung Cancer Colorectal Cancer Infectious Disease Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Myriad Genetic Laboratories, Inc., Qiagen Manchester, Ltd., Roche, Dako North America, Abbott, ICON plc, Illumina, Inc, Thermo Fisher
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Digital Companion Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Digital Companion Diagnostics Market report?

Ans: The main players in the Digital Companion Diagnostics Market are Myriad Genetic Laboratories, Inc., Qiagen Manchester, Ltd., Roche, Dako North America, Abbott, ICON plc, Illumina, Inc, Thermo Fisher

What are the Application segmentation covered in the Digital Companion Diagnostics Market report?

Ans: The Applications covered in the Digital Companion Diagnostics Market report are Breast Cancer, Melanoma, Lung Cancer, Colorectal Cancer, Infectious Disease, Others

What are the Type segmentation covered in the Digital Companion Diagnostics Market report?

Ans: The Types covered in the Digital Companion Diagnostics Market report are Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In Situ Hybridization (ISH), Next Generation Sequencing (NGS)

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Digital Companion Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Polymerase Chain Reaction (PCR)

1.2.3 Immunohistochemistry (IHC)

1.2.4 In Situ Hybridization (ISH)

1.2.5 Next Generation Sequencing (NGS)

1.3 Market by Application

1.3.1 Global Digital Companion Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Breast Cancer

1.3.3 Melanoma

1.3.4 Lung Cancer

1.3.5 Colorectal Cancer

1.3.6 Infectious Disease

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Digital Companion Diagnostics Market Perspective (2020-2031)

2.2 Global Digital Companion Diagnostics Growth Trends by Region

2.2.1 Global Digital Companion Diagnostics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Digital Companion Diagnostics Historic Market Size by Region (2020-2025)

2.2.3 Digital Companion Diagnostics Forecasted Market Size by Region (2026-2031)

2.3 Digital Companion Diagnostics Market Dynamics

2.3.1 Digital Companion Diagnostics Industry Trends

2.3.2 Digital Companion Diagnostics Market Drivers

2.3.3 Digital Companion Diagnostics Market Challenges

2.3.4 Digital Companion Diagnostics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Digital Companion Diagnostics Players by Revenue

3.1.1 Global Top Digital Companion Diagnostics Players by Revenue (2020-2025)

3.1.2 Global Digital Companion Diagnostics Revenue Market Share by Players (2020-2025)

3.2 Global Digital Companion Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Digital Companion Diagnostics Revenue

3.4 Global Digital Companion Diagnostics Market Concentration Ratio

3.4.1 Global Digital Companion Diagnostics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Digital Companion Diagnostics Revenue in 2024

3.5 Global Key Players of Digital Companion Diagnostics Head office and Area Served

3.6 Global Key Players of Digital Companion Diagnostics, Product and Application

3.7 Global Key Players of Digital Companion Diagnostics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Digital Companion Diagnostics Breakdown Data by Type

4.1 Global Digital Companion Diagnostics Historic Market Size by Type (2020-2025)

4.2 Global Digital Companion Diagnostics Forecasted Market Size by Type (2026-2031)

5 Digital Companion Diagnostics Breakdown Data by Application

5.1 Global Digital Companion Diagnostics Historic Market Size by Application (2020-2025)

5.2 Global Digital Companion Diagnostics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Digital Companion Diagnostics Market Size (2020-2031)

6.2 North America Digital Companion Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Digital Companion Diagnostics Market Size by Country (2020-2025)

6.4 North America Digital Companion Diagnostics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Digital Companion Diagnostics Market Size (2020-2031)

7.2 Europe Digital Companion Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Digital Companion Diagnostics Market Size by Country (2020-2025)

7.4 Europe Digital Companion Diagnostics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Digital Companion Diagnostics Market Size (2020-2031)

8.2 Asia-Pacific Digital Companion Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Digital Companion Diagnostics Market Size by Region (2020-2025)

8.4 Asia-Pacific Digital Companion Diagnostics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Digital Companion Diagnostics Market Size (2020-2031)

9.2 Latin America Digital Companion Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Digital Companion Diagnostics Market Size by Country (2020-2025)

9.4 Latin America Digital Companion Diagnostics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Digital Companion Diagnostics Market Size (2020-2031)

10.2 Middle East & Africa Digital Companion Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Digital Companion Diagnostics Market Size by Country (2020-2025)

10.4 Middle East & Africa Digital Companion Diagnostics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Myriad Genetic Laboratories, Inc.

11.1.1 Myriad Genetic Laboratories, Inc. Company Details

11.1.2 Myriad Genetic Laboratories, Inc. Business Overview

11.1.3 Myriad Genetic Laboratories, Inc. Digital Companion Diagnostics Introduction

11.1.4 Myriad Genetic Laboratories, Inc. Revenue in Digital Companion Diagnostics Business (2020-2025)

11.1.5 Myriad Genetic Laboratories, Inc. Recent Development

11.2 Qiagen Manchester, Ltd.

11.2.1 Qiagen Manchester, Ltd. Company Details

11.2.2 Qiagen Manchester, Ltd. Business Overview

11.2.3 Qiagen Manchester, Ltd. Digital Companion Diagnostics Introduction

11.2.4 Qiagen Manchester, Ltd. Revenue in Digital Companion Diagnostics Business (2020-2025)

11.2.5 Qiagen Manchester, Ltd. Recent Development

11.3 Roche

11.3.1 Roche Company Details

11.3.2 Roche Business Overview

11.3.3 Roche Digital Companion Diagnostics Introduction

11.3.4 Roche Revenue in Digital Companion Diagnostics Business (2020-2025)

11.3.5 Roche Recent Development

11.4 Dako North America

11.4.1 Dako North America Company Details

11.4.2 Dako North America Business Overview

11.4.3 Dako North America Digital Companion Diagnostics Introduction

11.4.4 Dako North America Revenue in Digital Companion Diagnostics Business (2020-2025)

11.4.5 Dako North America Recent Development

11.5 Abbott

11.5.1 Abbott Company Details

11.5.2 Abbott Business Overview

11.5.3 Abbott Digital Companion Diagnostics Introduction

11.5.4 Abbott Revenue in Digital Companion Diagnostics Business (2020-2025)

11.5.5 Abbott Recent Development

11.6 ICON plc

11.6.1 ICON plc Company Details

11.6.2 ICON plc Business Overview

11.6.3 ICON plc Digital Companion Diagnostics Introduction

11.6.4 ICON plc Revenue in Digital Companion Diagnostics Business (2020-2025)

11.6.5 ICON plc Recent Development

11.7 Illumina, Inc

11.7.1 Illumina, Inc Company Details

11.7.2 Illumina, Inc Business Overview

11.7.3 Illumina, Inc Digital Companion Diagnostics Introduction

11.7.4 Illumina, Inc Revenue in Digital Companion Diagnostics Business (2020-2025)

11.7.5 Illumina, Inc Recent Development

11.8 Thermo Fisher

11.8.1 Thermo Fisher Company Details

11.8.2 Thermo Fisher Business Overview

11.8.3 Thermo Fisher Digital Companion Diagnostics Introduction

11.8.4 Thermo Fisher Revenue in Digital Companion Diagnostics Business (2020-2025)

11.8.5 Thermo Fisher Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Myriad Genetic Laboratories Inc.

Roche

Abbott

ICON

Illumina Inc

Thermo Fisher

Qiagen Manchester, Ltd.

Dako North America

List of Tables

Table 1. Global Digital Companion Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Polymerase Chain Reaction (PCR)

Table 3. Key Players of Immunohistochemistry (IHC)

Table 4. Key Players of In Situ Hybridization (ISH)

Table 5. Key Players of Next Generation Sequencing (NGS)

Table 6. Global Digital Companion Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Digital Companion Diagnostics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Digital Companion Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 9. Global Digital Companion Diagnostics Market Share by Region (2020-2025)

Table 10. Global Digital Companion Diagnostics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 11. Global Digital Companion Diagnostics Market Share by Region (2026-2031)

Table 12. Digital Companion Diagnostics Market Trends

Table 13. Digital Companion Diagnostics Market Drivers

Table 14. Digital Companion Diagnostics Market Challenges

Table 15. Digital Companion Diagnostics Market Restraints

Table 16. Global Digital Companion Diagnostics Revenue by Players (2020-2025) & (US$ Million)

Table 17. Global Digital Companion Diagnostics Market Share by Players (2020-2025)

Table 18. Global Top Digital Companion Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Companion Diagnostics as of 2024)

Table 19. Ranking of Global Top Digital Companion Diagnostics Companies by Revenue (US$ Million) in 2024

Table 20. Global 5 Largest Players Market Share by Digital Companion Diagnostics Revenue (CR5 and HHI) & (2020-2025)

Table 21. Global Key Players of Digital Companion Diagnostics, Headquarters and Area Served

Table 22. Global Key Players of Digital Companion Diagnostics, Product and Application

Table 23. Global Key Players of Digital Companion Diagnostics, Date of Enter into This Industry

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Digital Companion Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 26. Global Digital Companion Diagnostics Revenue Market Share by Type (2020-2025)

Table 27. Global Digital Companion Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 28. Global Digital Companion Diagnostics Revenue Market Share by Type (2026-2031)

Table 29. Global Digital Companion Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 30. Global Digital Companion Diagnostics Revenue Market Share by Application (2020-2025)

Table 31. Global Digital Companion Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 32. Global Digital Companion Diagnostics Revenue Market Share by Application (2026-2031)

Table 33. North America Digital Companion Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 34. North America Digital Companion Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 35. North America Digital Companion Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 36. Europe Digital Companion Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. Europe Digital Companion Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 38. Europe Digital Companion Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 39. Asia-Pacific Digital Companion Diagnostics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 40. Asia-Pacific Digital Companion Diagnostics Market Size by Region (2020-2025) & (US$ Million)

Table 41. Asia-Pacific Digital Companion Diagnostics Market Size by Region (2026-2031) & (US$ Million)

Table 42. Latin America Digital Companion Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 43. Latin America Digital Companion Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 44. Latin America Digital Companion Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 45. Middle East & Africa Digital Companion Diagnostics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Middle East & Africa Digital Companion Diagnostics Market Size by Country (2020-2025) & (US$ Million)

Table 47. Middle East & Africa Digital Companion Diagnostics Market Size by Country (2026-2031) & (US$ Million)

Table 48. Myriad Genetic Laboratories, Inc. Company Details

Table 49. Myriad Genetic Laboratories, Inc. Business Overview

Table 50. Myriad Genetic Laboratories, Inc. Digital Companion Diagnostics Product

Table 51. Myriad Genetic Laboratories, Inc. Revenue in Digital Companion Diagnostics Business (2020-2025) & (US$ Million)

Table 52. Myriad Genetic Laboratories, Inc. Recent Development

Table 53. Qiagen Manchester, Ltd. Company Details

Table 54. Qiagen Manchester, Ltd. Business Overview

Table 55. Qiagen Manchester, Ltd. Digital Companion Diagnostics Product

Table 56. Qiagen Manchester, Ltd. Revenue in Digital Companion Diagnostics Business (2020-2025) & (US$ Million)

Table 57. Qiagen Manchester, Ltd. Recent Development

Table 58. Roche Company Details

Table 59. Roche Business Overview

Table 60. Roche Digital Companion Diagnostics Product

Table 61. Roche Revenue in Digital Companion Diagnostics Business (2020-2025) & (US$ Million)

Table 62. Roche Recent Development

Table 63. Dako North America Company Details

Table 64. Dako North America Business Overview

Table 65. Dako North America Digital Companion Diagnostics Product

Table 66. Dako North America Revenue in Digital Companion Diagnostics Business (2020-2025) & (US$ Million)

Table 67. Dako North America Recent Development

Table 68. Abbott Company Details

Table 69. Abbott Business Overview

Table 70. Abbott Digital Companion Diagnostics Product

Table 71. Abbott Revenue in Digital Companion Diagnostics Business (2020-2025) & (US$ Million)

Table 72. Abbott Recent Development

Table 73. ICON plc Company Details

Table 74. ICON plc Business Overview

Table 75. ICON plc Digital Companion Diagnostics Product

Table 76. ICON plc Revenue in Digital Companion Diagnostics Business (2020-2025) & (US$ Million)

Table 77. ICON plc Recent Development

Table 78. Illumina, Inc Company Details

Table 79. Illumina, Inc Business Overview

Table 80. Illumina, Inc Digital Companion Diagnostics Product

Table 81. Illumina, Inc Revenue in Digital Companion Diagnostics Business (2020-2025) & (US$ Million)

Table 82. Illumina, Inc Recent Development

Table 83. Thermo Fisher Company Details

Table 84. Thermo Fisher Business Overview

Table 85. Thermo Fisher Digital Companion Diagnostics Product

Table 86. Thermo Fisher Revenue in Digital Companion Diagnostics Business (2020-2025) & (US$ Million)

Table 87. Thermo Fisher Recent Development

Table 88. Research Programs/Design for This Report

Table 89. Key Data Information from Secondary Sources

Table 90. Key Data Information from Primary Sources

Table 91. Authors List of This Report

List of Figures

Figure 1. Digital Companion Diagnostics Picture

Figure 2. Global Digital Companion Diagnostics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Digital Companion Diagnostics Market Share by Type: 2024 VS 2031

Figure 4. Polymerase Chain Reaction (PCR) Features

Figure 5. Immunohistochemistry (IHC) Features

Figure 6. In Situ Hybridization (ISH) Features

Figure 7. Next Generation Sequencing (NGS) Features

Figure 8. Global Digital Companion Diagnostics Market Size by Application (2020-2031) & (US$ Million)

Figure 9. Global Digital Companion Diagnostics Market Share by Application: 2024 VS 2031

Figure 10. Breast Cancer Case Studies

Figure 11. Melanoma Case Studies

Figure 12. Lung Cancer Case Studies

Figure 13. Colorectal Cancer Case Studies

Figure 14. Infectious Disease Case Studies

Figure 15. Others Case Studies

Figure 16. Digital Companion Diagnostics Report Years Considered

Figure 17. Global Digital Companion Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Digital Companion Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Digital Companion Diagnostics Market Share by Region: 2024 VS 2031

Figure 20. Global Digital Companion Diagnostics Market Share by Players in 2024

Figure 21. Global Top Digital Companion Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Digital Companion Diagnostics as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Digital Companion Diagnostics Revenue in 2024

Figure 23. North America Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Digital Companion Diagnostics Market Share by Country (2020-2031)

Figure 25. United States Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Digital Companion Diagnostics Market Share by Country (2020-2031)

Figure 29. Germany Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Digital Companion Diagnostics Market Share by Region (2020-2031)

Figure 37. China Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Digital Companion Diagnostics Market Share by Country (2020-2031)

Figure 45. Mexico Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Digital Companion Diagnostics Market Share by Country (2020-2031)

Figure 49. Turkey Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Digital Companion Diagnostics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Myriad Genetic Laboratories, Inc. Revenue Growth Rate in Digital Companion Diagnostics Business (2020-2025)

Figure 53. Qiagen Manchester, Ltd. Revenue Growth Rate in Digital Companion Diagnostics Business (2020-2025)

Figure 54. Roche Revenue Growth Rate in Digital Companion Diagnostics Business (2020-2025)

Figure 55. Dako North America Revenue Growth Rate in Digital Companion Diagnostics Business (2020-2025)

Figure 56. Abbott Revenue Growth Rate in Digital Companion Diagnostics Business (2020-2025)

Figure 57. ICON plc Revenue Growth Rate in Digital Companion Diagnostics Business (2020-2025)

Figure 58. Illumina, Inc Revenue Growth Rate in Digital Companion Diagnostics Business (2020-2025)

Figure 59. Thermo Fisher Revenue Growth Rate in Digital Companion Diagnostics Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Cancer Companion Diagnostic Market Research Report 2024

Companion Diagnostic Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Companion Cancer Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Companion Diagnostics for Oncology Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncology Companion Diagnostic Market Research Report 2024

Global Companion Diagnostics Devices Market Research Report 2025

Companion Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Companion Diagnostics CDx Development Services Market Research Report 2024

In Vitro Diagnostic Medical Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Digital Diagnostics Market Research Report 2025

Global Digital Diagnostics System Market Research Report 2024

In Vitro Diagnosis IVD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Digital Visitor Management Software for Healthcare Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Connected Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Companion Scanner Market Research Report 2025

In Vitro Diagnostics Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

In vitro Diagnostics IVD Instruments Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Healthcare Companion Robots Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Medical Devices for Diagnostics in Vitro Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions